STORY SUMMARY
FDA Seeks Public Input to Support Ibogaine Research
The U.S. Food and Drug Administration today announced a request for information (RFI) describing approaches the agency is considering for the design of early-phase clinical trials of ibogaine drug products and seeking public input on those approaches.
This is a brief summary of reporting from FDA Press Releases. Read the original for the full article and context.